LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
WORX
SCWorx Corp.
There isn't enough reported data to score WORX yet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
WORX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
WORX's revenue is currently stable, but its profitability is under pressure. There isn't enough data to rate its cash flow and balance sheet.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
WORX PE Valuation
WORX has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
WORX Forward outlook
There aren't enough analyst estimates for WORX to show an outlook.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the stronger earnings trend. Trailing diluted EPS is up 51% for LLY versus WORX down 131%.
WORX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$174.60 | +$397.80 |
| Q2 2025 | -$196.20 | +$462.60 |
| Q1 2025 | -$160.20 | +$478.80 |
| Q4 2024 | -$140.40 | +$554.40 |
| Q3 2024 | -$572.40 | -$302.40 |
| Q2 2024 | -$658.80 | -$442.80 |
| Q1 2024 | -$639.00 | -$315.00 |
| Q4 2023 | -$694.80 | -$289.80 |
WORX is still losing money, but far less than before: $174.60 per share over the past year, against $972.00 at its worst in late 2021.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over WORX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over WORX on profitability, with a higher operating margin.
WORX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $706K | +3.4% |
| Q1 2026 | $744.9K | +3.4% |
| Q4 2025 | $768.9K | +14% |
| Q3 2025 | $705.8K | -7.1% |
| Q2 2025 | $682.6K | -8% |
| Q1 2025 | $720.3K | -11% |
| Q4 2024 | $675.7K | -26% |
| Q3 2024 | $759.7K | -16% |
WORX's revenue fell from its 2019 peak and has held roughly level since: $706,049 last quarter, up 3.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -17% | +26 points |
| Q1 2026 | -18% | +28 points |
| Q4 2025 | -25% | +31 points |
| Q3 2025 | -20% | +32 points |
| Q2 2025 | -43% | -1.6 points |
| Q1 2025 | -46% | -24 points |
| Q4 2024 | -56% | -51 points |
| Q3 2024 | -52% | +43 points |
WORX's operating margin was −17% last quarter, up 26 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the stronger cash trend. Its trailing FCF is up 259% versus its history, compared with WORX at down 25%.
WORX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$5.7K | +$646.1K |
| Q1 2026 | -$252.7K | +$151.9K |
| Q3 2025 | -$358.1K | +$4.5K |
| Q2 2025 | -$651.8K | -$124.1K |
| Q1 2025 | -$404.6K | -$345.1K |
| Q4 2024 | -$134.4K | -$29.6K |
| Q3 2024 | -$362.6K | +$10.2K |
| Q2 2024 | -$527.8K | -$180K |
WORX has burned cash in almost every quarter: −$1M over the past year, against −$1M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over WORX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
WORX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1% | +852 shares |
| 1 year | +735% | +78.6K shares |
| 3 years | +1897% | +84.8K shares |
| 5 years | +2406% | +85.7K shares |
WORX has 89,269 diluted shares, up 735% from a year ago.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
WORX Net Leverage
WORX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
WORX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.5 | Neutral |
| Stochastic | 4.1 | Oversold |
WORX's weekly RSI is 36 (neutral) and its Stochastic is 4 (oversold).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
WORX PE vs Healthcare Sector
WORX has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over WORX on trend strength, trading above more of its moving averages.
WORX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.39 | 47% below |
| 20 week MA | $4.13 | 69% below |
| 50 week MA | $19.4 | 93% below |
| 100 week MA | $80.5 | 98% below |
| 200 week MA | $313.5 | 100% below |
WORX is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over WORX on returns for 2026, with the stronger performance.
WORX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7,722.0 | $4,104.0 | -47% |
| 2021 | $4,104.0 | $3,699.0 | -9.9% |
| 2022 | $3,699.0 | $1,107.0 | -70% |
| 2023 | $1,107.0 | $331.2 | -70% |
| 2024 | $331.2 | $302.4 | -8.7% |
| 2025 | $302.4 | $37.8 | -88% |
| 2026 YTD | $37.8 | $1.27 | -97% |
WORX has finished every year since 2020 lower, and it's down 97% so far in 2026.